Company: CRNX
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0000950170-25-029050
Chunk: 298

Company: Crinetics Pharmaceuticals, Inc.
Filing Date: 2025-02-27
Form: 10-K
Item: Item 1B
Chunk 298
---
#
      
    Employment Agreement, effective as of June 15, 2018, by and between Alan Krasner, M.D. and the Registrant 
      
    S-1/A

    7/09/2018

    10.8

    10.10#
      
    Form of Indemnification Agreement for Directors and Officers
      
    S-1/A

    7/09/2018

    10.9

    10.11
      
    Lease Agreement, dated as of February 21, 2018, by and between 6262 Lusk Investors LLC and the Registrant, as amended 
      
    S-1

    6/22/2018

    10.9

    10.12†
     
    Lease Agreement, dated as of September 9, 2022, by and between San Diego 1 LLC and the Registrant
     
    10-Q

    11/14/2022

    10.1

    10.13
     
    First Amendment to Lease, dated December 8, 2023, to the Lease Agreement, dated as of September 9, 2022, by and between San Diego 1 LLC and the Registrant
     
    10-K

    2/28/2024

    10.14

    10.14#
     
    Non-Employee Director Compensation Program, as amended April 24, 2023
     
    10-Q

    5/09/2023

    10.2

    10.15#
     
    Crinetics Pharmaceuticals, Inc. 2021 Employment Inducement Incentive Award Plan and Form of Stock Option Agreement thereunder
     
    8-K

    12/23/2021

    10.1

    10.16#
     
    Amendment to the Crinetics Pharmaceuticals, Inc. 2021 Employment Inducement Incentive Award Plan
     
    10-Q

    11/14/2022

    10.3

    10.17#
     
    Amendment No. 2 to the Crinetics Pharmaceuticals, Inc. 2021 Employment Inducement Incentive Award Plan
     
    10-K

    2/28/2023

    10.19

    10.18#